COVID-19-Associated Mucormycosis: Identifying Mortality Predictors in a Retrospective Cohort Study.

Zahra Ghavami1, Mahboubeh Haddad1, Fereshte Sheybani1

  • 1Department of Infectious Diseases and Tropical Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

PubMed
Summary

COVID-19-associated mucormycosis (CAM) is a serious complication. Elevated CRP levels predict mortality, while prolonged antifungal treatment and posaconazole use improve survival in CAM patients.